A Look Across Continents at the Public & Plant Biotech
Oxford University Press has published a new edited volume featuring research on public opinion and media coverage of the plant biotech debate in the US, Europe, Africa, India,and Brazil. The volume is edited by Dominique Brossard and James Shanahan, professors at the University of Wisconsin-Madison and Cornell University respectively, along with Clint Nesbitt, a scientist at USDA.
Below is a table of contents. I contributed the chapter on "Where Do Science Debates Come From?," co-authored with Mike Huge, a graduate student I worked with at Ohio State.
Table of Contents
-Perspectives on communication about agricultural biotechnology.
-Public perceptions of agricultural biotechnology in Britain: the case of genetically modified foods.
-German reactions to genetic engineering in food production.
-Mass media and public perceptions of red and green biotechnology. A case study from Switzerland.
-Genetically Modified Foods: U.S. Public Opinion Research Polls.
-Biotechnology and consumer information.
-What do Brazilians think about transgenics?
-Where do science debates come from? Understanding attention cycles and framing.
-Opinion climates, spirals of silence, and biotechnology; Public opinion as a heuristic for scientific decision-making.
-The hostile media effect and opinions about biotechnology.
-Risk communication, risk beliefs, and democracy: The case of agricultural biotechnology
-The GEO-PIE Project: Case study of web-based outreach at Cornell University, USA.
-Governing controversial technologies: Consensus conferences as a communication tool.
-The Bt corn experience in the Philippines: A multi-stakeholder convergence.
-Food aid crisis and communication about GM foods: Experience from Southern Africa.
-Approval process and adoption of Bollgard Cotton in India :A private company perspective.
International poker champion Liv Boeree teaches decision-making for Big Think Edge.
"I was so moved when I saw the cells stir," said 90-year-old study co-author Akira Iritani. "I'd been hoping for this for 20 years."
- The team managed to stimulate nucleus-like structures to perform some biological processes, but not cell division.
- Unless better technology and DNA samples emerge in the future, it's unlikely that scientists will be able to clone a woolly mammoth.
- Still, studying the DNA of woolly mammoths provides valuable insights into the genetic adaptations that allowed them to survive in unique environments.
An MIT study predicts when artificial intelligence will take over for humans in different occupations.
While technology develops at exponential speed, transforming how we go about our everyday tasks and extending our lives, it also offers much to worry about. In particular, many top minds think that automation will cost humans their employment, with up to 47% of all jobs gone in the next 25 years. And chances are, this number could be even higher and the massive job loss will come earlier.
The blood of horseshoe crabs is harvested on a massive scale in order to retrieve a cell critical to medical research. However, recent innovations might make this practice obsolete.
- Horseshoe crabs' blue blood is so valuable that a quart of it can be sold for $15,000.
- This is because it contains a molecule that is crucial to the medical research community.
- Today, however, new innovations have resulted in a synthetic substitute that may end the practice of farming horseshoe crabs for their blood.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.